The synthesis and antibacterial activity of a series of 7V-acyl 3-isopropylidenyl-and 3-isopropyl 2-azetidinones having potent in vitro antibacterial activity, particularly against anaerobic organisms, is described. A distinguishing structural feature of these compounds is the lack of any ionizable moiety appendant to the lactam nitrogen.
2-azetidinone 1 and the above described hydroxyisopropylidene templates.10) Acylation of 1 to give compoundsin the a series was carried out using either the appropriate carboxylic acid anhydride and dimethylaminopyridine (DMAP) in pyridine (Method A), the acid chloride and triethylamine in methylene chloride (Method B), or the carboxylic acid and dicyclohexylcarbodiimide in tetrahydrofuran (Method C). Thus we obtained the "alkanoyl-activated" 7V-acyl 3-alkylidene 2-azetidinones 2a~7a and 13a~18a which were generally isolated as colorless oils upon silica gel chromatography (Scheme 1).
The "ester-activated" analogs 9a~12a were derived by the coupling of 1 with excess chloroformate (to effect a reasonable degree of conversion) in the presence of triethylamine and DMAP in methylene chloride (Scheme 2). palladium on charcoal catalyst (1 atm hydrogen, ethyl acetate) cleanly provided in excellent yields the corresponding racemic 7V-acyl 3-isopropyl azetidin-2-one analogs 2b~18b. The N-(5-hydroxypentanoyl) 3-isopropyl analog 16b was obtained upon acid-catalyzed hydrogenolysis of benzyl ether 15b.1"
In Vitro Antibacterial Activity Table 1 gives the zones of inhibition for all susceptible organisms, for the N-acyl 3-isopropylidene-and 3-isopropyl azetidin-2-ones, as determined by a standard agar diffusion assay. Extremely large zones of inhibition were observed upon dipped-disk assay for those compounds lacking additional heteroatoms within the N-l alkanoyl chain. Against all susceptible organisms, the optimal chain length of these simple alkanoyl substituted analogs (2a, 2b~7a,8b) was a length of 5~6 carbons. The 7V-pentanoyl 4b and iV-hexanoyl 5b analogs exhibited some of the most dramatically-large zones. When5b was tested at a solution concentration of 1 mg/ml (approx 80 /ig/12.7 mmdisk) against Bacteroidesfragilis UC 6513, a zone of 154mmdiameter was observed; at 1,000-fold lower loading (80 ng/disk), a 30-mm zone of inhibition was obtained. Such uncharacteristically-immense zones were also observed against Clostridium perfringens UC6509, and a number of Gram-positive facultative organisms, including the multiply-resistant strain Staphylococcus aureus UC6685.
These lipophilic compounds exhibited a marked atypical zone size-minimum inhibitory concentration (MIC) correlation. In general, only those analogs producing zones of inhibition > 50mmat 80/ig/disk exhibited correspondingly low MICvalues (Tables 1 and 2) . No Gram-negative aerobe activity was observed for any memberof this class. The poor MICresults for all compoundsvs. C. perfringens maybe associated with the presence of resistant colonies within the large zones of inhibition, which was observed for a number of analogs.
The highly lipophilic nature of compounds 2a, 2b~lla, lib is reflected in the low aqueous solubilities, particularly of the analogs with aliphatic chains like 5b ( < 1 mg/ml). In order to generate more water-soluble compounds, without resorting to the introduction of a charged group, we synthesized a series of analogs having 1~2 oxygen atoms incorporated into the 7V-acyl chain (12a, 12b~18a, 18b). Several of the compounds showed greatly improved water solubility, e.g., methoxy ether 12a (20mg/ml), and methyl ketone 17a (7 mg/ml). For these more soluble analogs, somewhatmore typical zone size-MIC correlations were observed.
In our systematic substitution of oxygen for CH2units within the N-acyl chain, we discovered analog 10a, which has the highest overall in vitro potency (Table 2 ). This propyl ester-activated 3-isopropylidene azetidin-2-one is unlike any other congener, in that 10a was 2~8 times more potent than its corresponding isopropyl analog 10b. Homologous esters in the ethyl (9a and 9b) and butyl (lla and lib) series were significantly less active than 10a.
The highest in vitro activity of these compoundsis found vs. anaerobes of the Bacteroides species (Table 2) . Analog 10a is extremely potent vs. Bacteroides thetaiotaomicron UC9014 and UC6611, and B. fragilis UC 9370, compared with clindamycin. TV-(Ethoxyacetyl) 3-isopropylidene 13a was comparable in activity to clindamycin vs. three B. fragilis strains, and showed moderate activity vs. Staphylococcus epidermidis UC 30033. Both 10a and 10b, as well as the methoxy (14b) S. epidermidis UC 30031. While the iV-hexanoyl isopropyl analog 5b also exhibited potent activity vs. anaerobes, against S. aureus strains (UC 6675, UC3665, and UC6685), significant, but only partial inhibition was effected at low levels (4//g/ml). For these strains, partial growth at higher drug levels was observed upon close visual examination, evidenced by the presence of two or more colonies, and FEB. 1992 thus preventing assignment of the lower endpoint as the MIC. In Vivo Activity
None of the compounds tested in vivo at levels up to 50mg/kg elicited a reproducible therapeutic response in mice experimentally-infected with either S. epidermidis UC 12084, S. aureus UC 9271 or UC 6685, when administered orally or subcutaneously. The compounds were not tested in vivo against anaerobic bacteria.
Conclusions
It is to be noted that a prevalent structural feature of these 7V-acyl 3-alkylidenyl and 3-alkyl 2-azetidinones is that these are non-ionizable molecules, devoid of any charged appendage about the N-l nitrogen, as will be found to date in all other /Mactam antibiotics exhibiting significant in vitro potency levels.13~15) As such, these interesting synthetic substances can be considered as comprising a new class of monocyclic /Mactam antibacterial agents.
Whatever degree of activation the /Mactam carbonyl is afforded from the strain induced by the appendage of a double bond exocyclic to the ring, the net electrophilicity is attenuated as a consequence of resonance bonding of the conjugated system.16) This is evident upon examination of the respective IR frequencies of any a/b analog pair having an identical N-l group: the 3-isopropyl azetidinone carbonyl always has a higher energy stretching frequency (approximately 10 cm" 1) than that of the corresponding isopropylidene analog. Thus the dihydro b analog apparently possesses the more chemically-reactive carbonyl,6'17) which may be reflected in the biological results. In all cases, save the previously noted 10a, the isopropyl b congener is the more active of any given a/b pair having identical N-l substituents. 7V-Acyl substitution alone is therefore sufficient to induce a high degree of chemical reactivity to 3-alkyl 2-azetidinones.18) This has also subsequently been demonstrated by Thomas and Williams, 19) where they activated a 3,3,4-trialkyl-substituted 2-azetidinone toward intramolecular ring opening by acylation on nitrogen, for the purpose of constructing the <5-lactone fragment of the lankacidins. Hence our rationalized dual requirements of augmentedring strain and electronic withdrawal have proven overly exacting.
Any correlation of antibacterial potency with IR carbonyl stretching frequencies without consideration of the differential stereochemical biases involved upon binding an essentially planar 3-isopropylidene /Mactam molecule (a), vs. a non-planar enantiomer of the 3-isopropyl derivative (b), would be shortsighted. Potentiation of antibacterial activity between the diastereomeric 3-(monosubstituted)isopropyl iV-acyl 2-azetidinones has been observed; those SARstudies, together with /Mactamase stabilities and mechanism of action studies, will be discussed in later publications. Subsequent to our preliminary disclosures1~3) that uncharged 7V-acyl groups sufficiently activate a 3-alkyl-substituted azetidin-2-one to engender potent antimicrobial activity, Firestone et al. 1 8) reported on related 4-acetoxy-substituted A^-acyl 3-alkyl 2-azetidinones which acylate and then deactivate the serine protease humanleukocyte elastase.
Experimental
Disk Diffusion Assay Standardized cell suspensions (inocula) were prepared and stored frozen in the vapor phase of a liquid nitrogen freezer, then thawed at roomtemperature on the day of assay. Anagar mediumwhich best supported the growth of each test organism was prepared and sterilized. The media employedwere as VOL.45 NO.2 THE JOURNAL OF ANTIBIOTICS 219 follows: Nutrient agar for S. aureus UC 3665; Schaedler agar for B. fragilis UC 6513; brain heart infusion agar for C. perfringens UC6509; Mueller-Hinton agar for S. aureus UC6685 and S. epidermidis UC 719; and Mueller-Hinton agar supplemented with 5% defibrinated sheeps's blood for Streptococcus pneumoniae UC9207. The agar was cooled to 45~50°C prior to being inoculated with the microorganism. The cooled, inoculated medium was poured into a Nunc Bioassay dish (248mm x 248mm, 100ml per dish), and allowed to solidify at room temperature. Drug-impregnated paper disks were then placed on the surface of the agar mediumwith a forceps. The dishes were incubated for 20 hours at 35°C. The anaerobic organisms were incubated in a Coy Anaerobic glovebox with an atmosphere of 85%nitrogen, 10%hydrogen, and 5%carbon dioxide. After incubation, the size of the zone of inhibition was read to the nearest millimeter and recorded.
In Vitro MICAssay IR spectra were determined on either a Perkin-Elmer Infracord or 298 Spectrophotomer, or determined by the Physical and Analytical Chemistry Laboratory, The Upjohn Company. *H NMRwere determined on either a Varian EM390 (90MHz), or a Bruker AM300 (300MHz) spectrometer. Chemical shifts are reported in S units, down field from TMS. Low resolution electron impact (El) mass spectra were obtained on a CEC-21-110B or a Finnigan MAT8230B or a Finnigan (Varian) MATCH-7Amass spectrometer at 70 eV using the direct probe. High resolution measurements were obtained on either the CEC-21-1 10B or MAT8230B instruments via the peak matching technique. Lowresolution chemical ionization spectra were obtained on the MATCH-7Ausing ammonia, isobutane, or methane as CI gas. FABmass spectra of compounds were obtained on a Finnigan (Varian) MATCH5-DFinstrument modified for fast atom bombardment (FAB) ionization. The instrument was set up with xenon or argon as the bombarding gas at 8 kV. The data were acquired and analyzed using the UPACS-II data system. Each compound was run using glycerol-thioglycerol (3 : 1) or 2-hydroxyethyldisulfide (2-HED) as the matrix. In an attempt to confirm the empirical formulas of the compounds, the exact masses of (M+H)+ ions were measured,via the peak matching technique. The ions were measured against known cluster adducts of the glycerol -thioglycerol or 2-HEDmatrix, or ions of polypropyleneglycol added as a reference material. TLCanalysis was carried out on glass plates coated with silica gel G (Analtech). Preparative TLC was carried out on 1,000/an or 2,000/an thick silica gel 20cmx20cm plates (Analtech). Column chromatography was carried out using Silica gel 60 (40~63/an, E. Merck, Darmstadt), typically on a 5.0 cmx 0.5 cm column. Visualization of TLCplates was with /?-anisaldehyde staining or UVlight. For the isopropylidenyl analogs 2a~18a, the spectral data is tabulated in Tables 3 and 4 ; similarly, the data for the isopropyl compounds is found in Tables 4 and 5 . The parent 3-isopropylidene 2-azetidinone (1) was prepared as previously described;10) additional unpublished physical data is given below and in Table3. 3-(l-Methylethylidene)-2-oxo-l-azetidine (1) (U-71 1 17)1O) MP 156~158°C. Anal Calcd for C6H9NO: C 64. 84, H 8.16, N 12.60. Found: C 64.86, H 8.18, N 12.67. A^-Acyl-3-isopropylidene Azetidin-2-ones (2a~5a) General Procedure A) Anhydride: 3a (U-70906): A mixture of 0.024g (0.217mmol) of 1, 0.032g (0.26 mmol) of 4-J/V,7V-dimethylaminopyridine, and 0.049 ml (0.25 mmol) of valeric anhydride in 0.5 ml of pyridine was stirred at 20°C for 3 hours. The volatiles were removed in vacuo, and the residue purified by preparative TLC (1,000/mi silica gel, EtOAc-hexane (Hex), 1 : 1 to give 0.28g (64%) of 3a as a colorless oil. Table 5 . 13C NMR data (75.47MHz, CDC13).
iV-Acyl 3-Isopropylidene Azetidin-2-ones (6a~7a) General Procedure B) Acid Chloride: 6a (U-70965): To a solution of 0.025g (0.23mmol) of 1 in 5ml of methylene chloride at 0°C under argon was added 0.041 ml (0.29mmol) of triethylamine, then over 1 minute, 0.051 ml (0.30mmol) ofoctanoyl chloride. The mixture was allowed to stir at 20°C for 1.3 hours, then additional amounts (as above) each of triethylamine and octanoyl chloride were added, and again after an additional 2 hours. The mixture was stirred for 22 hours, then concentrated in vacuo. The residue was purified by preparative TLC (conditions as for 3a) to give 0.38g (71%) of 6a as an oil.
N-Acyl 3-Isopropylidene
Azetidin-2-ones (13a~18a) General Procedure C) Dicyclohexylcarbodiimide
Coupling: 13a (U-80443): To a mixture of 0.020 g (0.18mmol) of 1, 0.035g (0.29mmol) of N,N-dimethylamino pyridine, and 0.055g (0.53mmol) of ethoxyacetic acid in 1.0ml of dichloromethane at 20°C under argon was added 0.131 g (0.64mmol) of dicyclohexylcarbodiimide, and the mixture stirred for 4 hours. The mixture was filtered and the solid was washed with dichloromethane, and the combined filtrates were concentrated in vacuo. The residue was purified by preparative TLC (1,000pm silica gel, EtOAc-Hex, 30 : 70, 3 elutions) to give 0.027 g (76%) of 13a as a white solid, mp 63~65°C.
TV-Carboxylic Acid 3-Isopropylidene Azetidin-2-one Esters (9a~12a) General Procedure: 10a (U-80765). To a solution of0.032g (0.29mmol) of 1 and 0.052g (0.43 mmol) of iV,AT-dimethylaminopyridine in 2.5 ml of triethylamine -methylene chloride, 80 : 20 at 0°C was added 12\A (0.64mmol) of w-propyl chloroformate dropwise over 1 minute. After 7 hours, an additional 72^1
